AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Rises 326.6%

AB Corporate Bond ETF (NASDAQ:EYEG) was the recipient of a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 465 shares, an increase of 326.6% from the September 15th total of 109 shares. Based on an average daily volume of 374 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.0% of the shares of the company are sold short.

AB Corporate Bond ETF Stock Performance

AB Corporate Bond ETF stock traded down $0.07 during trading hours on Friday, reaching $33.39. 5 shares of the company were exchanged, compared to its average volume of 312. The firm has a market cap of $26.71 million, a price-to-earnings ratio of -19.88 and a beta of 0.20. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.01. The stock has a 50-day moving average of $34.17 and a 200 day moving average of $34.81. AB Corporate Bond ETF has a 12 month low of $33.24 and a 12 month high of $36.63.

AB Corporate Bond ETF Increases Dividend

The company also recently disclosed a monthly dividend, which was paid on Tuesday, October 6th. Investors of record on Thursday, October 1st were issued a dividend of $0.1367 per share. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $1.64 annualized dividend and a dividend yield of 4.9%. This is an increase from AB Corporate Bond ETF’s previous monthly dividend of $0.1284. AB Corporate Bond ETF’s payout ratio is currently -101.79%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.